Name: UMIN ID:
Unique ID issued by UMIN | UMIN000018171 |
---|---|
Receipt number | R000020978 |
Scientific Title | A prospective, multicenter, Phase II study to evaluate the safety and efficacy of eculizumab in subjects with Guillain-Barre syndrome |
Date of disclosure of the study information | 2015/07/02 |
Last modified on | 2017/05/27 12:04:41 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/07/02 21:09:02 | ||
2 | Update | 2015/11/21 11:52:05 | Recruitment status |
|
3 | Update | 2016/04/23 21:25:12 | Recruitment status |
|
4 | Update | 2017/05/27 12:04:41 | Recruitment status |